NEWS | Innovation for Life
Prestige Biopharma IDC, a leading figure in antibody drug research, stood prominently as it participated in the '2023 Global He
Prestige Biopharma IDC, a leading figure in antibody drug research, stood prominently as it participated in the '2023 Global Healthcare Week.'
August 22, 2023 - The event took place at BEXCO in Busan for three days starting from the 17th, featuring an opening ceremony with ribbon-cutting and participation in exhibition booths. During the event, Prestige Biopharma IDC, represented by CEO Seok Jae SEO, revealed its cutting-edge advancements in antibody drug research and development. The event, characterized as an integrated healthcare exhibition, was organized based on active support for the life care industry, one of Busan Metropolitan City's seven major strategic industries. The company also explained that it engaged in numerous meetings with industry stakeholders and domestic institutions to foster strategic partnerships.
This event is the 6th edition held this year, with participation from 148 healthcare-related institutions. 29% increase compared to the previous year's participation of 115 institutions. With comprehensive support from Busan Metropolitan City, the event has grown significantly into a global bio event. Prestige Biopharma IDC, actively engaged in developing antibody pharmaceuticals, including for pancreatic cancer, shared that it utilized this event to discuss and formulate practical business strategies with various stakeholders in the healthcare industry, including medical experts.
Especially noteworthy was the opening ceremony on the 17th, where Prestige Biopharma IDC's CEO, Seokjae SEO, joined key figures such as Economic Deputy Mayor Seongkwon Lee, Future Industries Director Gyeongdeok Lee, Director of Eunseong Medical Foundation, Namgyeongchan, President of the Korea Medical Devices Distribution Association, Buyeolkwang Branch, Gangbyeongsu of KOTRA Busan, Secretary General Kim Byeonggun of Busan Healthcare Industry Association, Director of the Innovative Health Convergence College at Dong-eui University, Gyeongtae Jeong, and Director of Industrial Promotion Support at Busan Economic Promotion Agency, Jihwan Oh, in cutting the opening ceremony ribbon. Subsequently, the company actively promoted various bio healthcare research activities, ranging from antibody drugs, biosimilars, vaccines to diagnostics, through its dedicated exhibition booth. Of particular significance was the opportunity to discuss the promotion of industrial growth at the Busan level and the establishment of a healthcare cluster.
CEO Seokjae SEO of Prestige Biopharma IDC commented, "This event in Busan, where the significance of a healthy life has been highlighted even more after the post-COVID-19 era, was a meaningful occasion to promote various new drug research efforts that the company is undertaking for the sake of 'innovation for life.' Through this event, along with the cooperation of newly established relationships within the medical industry and comprehensive support from Busan Metropolitan City, we will solidify our position as a company that contributes to improving national health and promoting global healthcare in the post-pandemic era."
Meanwhile, at Prestige Biopharma Group's Innovative Discovery Center (IDC), responsible for antibody drug development, core projects including the development of antibody drug PBP1510 for pancreatic cancer and a diagnostic kit for the same disease are being actively pursued. With Prestige Biopharma recently joining the 'Cancer Moonshot' project, a cancer conquest initiative led by U.S. President Joe Biden, related research is advancing vigorously.
<picture : Seok Jae SEO, CEO of Prestige Biopharma IDC (fifth from the right), participating in the ribbon-cutting ceremony of the '2023 Global Healthcare Week,' held at BEXCO in Busan from the 18th to the 3rd for three days.>
<picture : View of the Prestige Biopharma IDC booth participating in the '2023 Global Healthcare Week,' held at BEXCO in Busan from the 18th to the 3rd for three days.>